Vitronectin - Master controller or micromanager?

IUBMB Life

Volumn 65, Issue 10, 2013, Pages 807-818

  Leavesley, David I ^a   Kashyap, Abhishek S ^a   Croll, Tristan ^a   Sivaramakrishnan, Manaswini ^a   Shokoohmand, Ali ^a   Hollier, Brett G ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

coagulation; extracellular matrix; growth factor; multi protein complex; thrombogenesis; vitronectin

Indexed keywords

CELL SURFACE RECEPTOR; MONOMER; MULTIPROTEIN COMPLEX; POLYMER; POLYPEPTIDE; PROTEIN S; VITRONECTIN;

ANGIOGENESIS; BLOOD CLOTTING; CANCER GROWTH; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LIVER CELL; MICROENVIRONMENT; MOLECULAR INTERACTION; NONHUMAN; PROTEIN CONFORMATION; REVIEW; TISSUE REPAIR; VASCULARIZATION; WOUND HEALING;

ANIMALIA; MAMMALIA;

COAGULATION; EXTRACELLULAR MATRIX; GROWTH FACTOR; MULTI-PROTEIN COMPLEX; THROMBOGENESIS; VITRONECTIN;

ANIMALS; BLOOD COAGULATION; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; VITRONECTIN; WOUND HEALING;

EID: 84884976902     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1203     Document Type: Review

References (136)

1. Holmes, R., (1967) Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J. Cell Biol. 32, 297-308.
2. Grinnell, F., Hays, D. G., and, Minter, D., (1977) Cell adhesion and spreading factor. Partial purification and properties. Exp. Cell Res. 110, 175-190. (Pubitemid 8243348)
3. Kolb, W. P., and, Muller-Eberhard, H. J., (1975) The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J. Exp. Med. 141, 24-35.
4. Declerck, P. J., De Mol M., Alessi M. C., Baudner S., Paques E. P., et al. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J. Biol. Chem. 263, 15454-15461.
5. Seiffert, D., and, Loskutoff D. J., (1991) Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J. Biol. Chem. 266, 2824-2830. (Pubitemid 21909141)
6. Stenn, K. S., (1981) Epibolin: a protein of human plasma that supports epithelial cell movement. Proc. Natl. Acad. Sci. USA 78, 6907-6911. (Pubitemid 12216871)
7. Podack, E. R., and, Muller-Eberhard, H. J., (1979) Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J. Biol. Chem. 254, 9808-9814.
8. Yang, M., Murray, M. T., and, Kurkinen, M., (1997) A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J. Biol. Chem. 272, 13527-13533. (Pubitemid 27224781)
9. Preissner, K. T., and, Seiffert, D., (1998) Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb. Res. 89, 1-21. (Pubitemid 28231482)
10. Izumi, M., Yamada, K. M., and, Hayashi, M., (1989) Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochim. Biophys. Acta 990, 101-108. (Pubitemid 19055401)
11. Preissner, K. T., (1991) Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 7, 275-310.
12. Schvartz, I., Seger, D., and, Shaltiel, S., (1999) Vitronectin. Int. J. Biochem. Cell Biol. 31, 539-544. (Pubitemid 29219400)
13. Seiffert, D., Keeton, M., Eguchi, Y., Sawdey, M., and, Loskutoff, D. J., (1991) Detection of vitronectin mRNA in tissues and cells of the mouse. Proc. Natl. Acad. Sci. USA 88, 9402-9406. (Pubitemid 21915639)
14. Panetti, T. S., Wilcox S. A., Horzempa C., and, McKeown-Longo, P. J., (1995) Alpha v beta 5 integrin receptor-mediated endocytosis of vitronectin is protein kinase C-dependent. J. Biol. Chem. 270, 18593-18597.
15. Seiffert, D., (1997) Constitutive and regulated expression of vitronectin. Histol. Histopathol. 12, 787-797. (Pubitemid 27314710)
16. Sheehan, M., Morris, C. A., Pussell, B. A., and, Charlesworth, J. A., (1995) Complement inhibition by human vitronectin involves non-heparin binding domains. Clin. Exp. Immunol. 101, 136-141.
17. Podor, T. J., Campbell, S., Chindemi, P., Foulon, D. M., Farrell, D. H., et al. (2002) Incorporation of vitronectin into fibrin clots. J. Biol. Chem. 277, 7520-7528.
18. Tomasini, B. R., (1988) Characterization of Vitronectin: Interactions with Components of the Blood Coagulation System. University of Wisconsin, Madison.
19. Stepanek, O., Brdicka, T., Angelisova, P., Horvath, O., Spicka, J., et al. (2011) Interaction of late apoptotic and necrotic cells with vitronectin. PLoS One 6, e19243.
20. Gladson, C. L., and, Cheresh, D. A., (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J. Clin. Invest. 88, 1924-1932.
21. Tomasini-Johansson, B. R., Sundberg, C., Lindmark, G., Gailit, J. O., and, Rubin, K., (1994) Vitronectin in colorectal adenocarcinoma-synthesis by stromal cells in culture. Exp. Cell Res. 214, 303-312. (Pubitemid 24302406)
22. Aaboe, M., Offersen, B. V., Christensen, A., and, Andreasen, P. A., (2003) Vitronectin in human breast carcinomas. Biochim. Biophys. Acta 1638, 72-82. (Pubitemid 36577374)
23. Loridon-Rosa, B., Vielh, P., Cuadrado, C., and, Burtin, P., (1988) Comparative distribution of fibronectin and vitronectin in human breast and colon carcinomas. An immunofluorescence study. Am. J. Clin. Pathol. 90, 7-16.
24. Niculescu, F., Rus, H. G., Retegan, M., and, Vlaicu, R., (1992) Persistent complement activation on tumor cells in breast cancer. Am. J. Pathol. 140, 1039-1043.
25. Seger, D., Gechtman, Z., and, Shaltiel, S., (1998). Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading. J. Biol. Chem. 273, 24805-24813. (Pubitemid 28454985)
26. Stockmann, A., Hess, S., Declerck, P., Timpl, R., and, Preissner, K. T., (1993) Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J. Biol. Chem. 268, 22874-22882. (Pubitemid 23318352)
27. Seiffert, D., and, Loskutoff, D. J., (1996) Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo. J. Biol. Chem. 271, 29644-29651. (Pubitemid 26389588)
28. Gijsbers, R., Ceulemans, H., and, Bollen, M., (2003) Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1. Biochem. J. 371, 321-330. (Pubitemid 36547614)
29. Bornstein, P., (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130, 503-506.
30. Yu, Y., Hoffhines, A. J., Moore, K. L., and, Leary, J. A., (2007) Determination of the sites of tyrosine O-sulfation in peptides and proteins. Nat. Methods 4, 583-538.
31. Lynn, G. W., Heller, W. T., Mayasundari, A., Minor, K. H., and, Peterson, C. B., (2005) A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry 44, 565-574. (Pubitemid 40105487)
32. Sivaramakrishnan, M., Shooter, G. K., Upton, Z., and, Croll, T. I., (2013) Transglutaminases and receptor tyrosine kinases. Amino Acids 44, 19-24.
33. Skorstengaard, K., Halkier, T., Hojrup, P., and, Mosher, D., (1990) Sequence location of a putative transglutaminase cross-linking site in human vitronectin. FEBS Lett. 262, 269-274. (Pubitemid 20104315)
34. Fryklund, L., and, Sievertsson, H., (1978). Primary structure of somatomedin B: a growth hormone-dependent serum factor with protease inhibiting activity. FEBS Lett. 87, 55-60. (Pubitemid 8285600)
35. Strändker, L., Enger, A., Schultz-Knappe, P., Wohn, K.-D., Germer, M., et al. (1996) Structural and functional characterization of vitronectin-derived RGD-containing peptides from human hemofiltrate. Eur. J. Biochem. 241, 557-563. (Pubitemid 26356846)
36. Altruda, F., and, Tolosano, E., 2002. Hemopexin: structure, function, and regulation. DNA Cell Biol. 21, 297-306. (Pubitemid 34594543)
37. Piccard, H., Van den Steen, P. E., and, Opdenakker, G., (2007) Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins. J. Leukoc. Biol. 81, 870-892. (Pubitemid 46495636)
38. Schoppet, M., Chavakis, T., Al-Fakhri, N., Kanse, S. M., and, Preissner, K. T., (2002). Molecular interactions and functional interference between vitronectin and transforming growth factor-beta. Lab. Invest. 82, 37-46. (Pubitemid 34072644)
39. Kricker, J. A., Towne, C. L., Firth, S. M., Herington, A. C., and, Upton, Z., (2003) Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144, 2807-2815. (Pubitemid 36819880)
40. Nam, T., Moralez, A., and, Clemmons, D., (2002) Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143, 30-36. (Pubitemid 34056400)
41. Upton, Z., Webb, H., Hale, K., Yandell, C. A., McMurtry, J. P., et al. (1999) Identification of vitronectin as a novel insulin-like growth factor-II binding protein. Endocrinology 140, 2928-2931. (Pubitemid 32245176)
42. Zannettino, A. C., Holding, C. A., Diamond, P., Atkins, G. J., Kostakis, P., et al. (2005) Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J. Cell. Physiol. 204, 714-723. (Pubitemid 40934668)
43. Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., et al. (2005). Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. Biomed. Chromatogr. Cell Biol. 6, 8.
44. Hildebrand, A., Preissner, K. T., Müller-Berghaus, G., and, Teschemacher, H., (1989) A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for beta-endorphin upon interaction with heparin or surfaces. J. Biol. Chem. 264, 15429-15434. (Pubitemid 19242915)
45. Ignotz, R. A., Heino, J., and, Massague, J., (1989) Regulation of cell adhesion receptors by transforming growth factor-beta. Regulation of vitronectin receptor and LFA-1. J. Biol. Chem. 264, 389-392. (Pubitemid 19027616)
46. Pons, S., and, Marti, E., (2000) Sonic hedgehog synergizes with the extracellular matrix protein vitronectin to induce spinal motor neuron differentiation. Development 127, 333-342. (Pubitemid 30087969)
47. Chain, D., Kreizman, T., Shapira, H., and, Shaltiel, S., (1991) Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1. FEBS Lett. 285, 251-256.
48. Deng, G., Royle, G., Wang, S., Crain, K., and, Loskutoff, D. J., (1996) Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin. J. Biol. Chem. 271, 12716-12723.
49. Bafetti, L. M., Young, T. N., Itoh, Y., and, Stack, M. S., (1998) Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 273, 143-149. (Pubitemid 28042187)
50. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., et al. (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697.
51. Marchenko, G. N., Ratnikov, B. I., Rozanov, D. V., Godzik, A., Deryugina, E. I., et al. (2001) Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem. J. 356, 705-718. (Pubitemid 32588442)
52. Ghosh, M. C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and, Diamandis, E. P., (2004) Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193-199. (Pubitemid 39551746)
53. Gechtman, Z., and, Shaltiel, S., (1997) Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin. Eur. J. Biochem. 243, 493-501. (Pubitemid 27060708)
54. Clyman, R. I., Mauray, F., and, Kramer, R. H., (1992) Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp. Cell Res. 200, 272-284.
55. Weinacker, A., Chen, A., Agrez, M., Cone, R. I., Nishimura, S., et al. (1994) Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J. Biol. Chem. 269, 6940-6948.
56. Cambier, S., Mu, D. Z., O'Connell, D., Boylen, K., Travis, W., et al. (2000) A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. Cancer Res. 60, 7084-7093. (Pubitemid 32059188)
57. Schnapp, L. M., Hatch, N., Ramos, D. M., Klimanskaya, I. V., Sheppard, D., et al. (1995) The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J. Biol. Chem. 270, 23196-23202.
58. Kost, C., Benner, K., Stockmann, A., Linder, D., and, Preissner, K. T., (1996) Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor. Eur. J. Biochem. 236, 682-688.
59. Chavakis, T., Kanse, S. M., Lupu, F., Hammes, H. P., Muller-Esterl, W., et al. (2000) Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 96, 514-522. (Pubitemid 30463370)
60. Otsuka, A., Hirose, K., Kilimann, M. W., and, Kamata, T., (2003). Amphiphysin1 inhibits vitronectin-mediated cell adhesion, spreading, and migration in vitro. Biochem. Biophys. Res. Commun. 301, 769-775. (Pubitemid 36268956)
61. Carlson, T. R., Feng, Y., Maisonpierre, P. C., Mrksich, M., and, Morla, A. O., (2001) Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276, 26516-26525.
62. Ill, C. R., and, Ruoslahti, E., (1985) Association of thrombin-antithrombin III complex with vitronectin in serum. J. Biol. Chem. 260, 15610-15615. (Pubitemid 16173185)
63. Chain, D., Korc-Grodzicki, B., Kreizman, T., and, Shaltiel, S., (1991) Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A. Biochem. J. 274, 387-394.
64. Mueller, S., and, Wimmer, E., (2003) Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains. J. Biol. Chem. 278, 31251-31260. (Pubitemid 36994642)
65. Lange, R., Peng, X., Wimmer, E., Lipp, M., and, Bernhardt, G., (2001). The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285, 218-227. (Pubitemid 32641883)
66. Sanghi, S., Kumar, R., Lumsden, A., Dickinson, D., Klepeis, V., et al. (2001) cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland. J. Mol. Biol. 310, 127-139. (Pubitemid 32619957)
67. Gebb, C., Hayman, E. G., Engvall, E., and, Ruoslahti, E., (1986) Interaction of vitronectin with collagen. J. Biol. Chem. 261, 16698-16703. (Pubitemid 17000859)
68. Rosenblatt, S., Bassuk, J. A., Alpers, C. E., Sage, E. H., Timpl, R., and, Preissner, K. T., (1997) Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem. J. 324, 311-319. (Pubitemid 27229398)
69. Wilkins-Port, C. E., Sanderson, R. D., Tominna-Sebald, E., and, McKeown-Longo, P. J., (2003) Vitronectin's basic domain is a syndecan ligand which functions in trans to regulate vitronectin turnover. Cell Commun. Adhes. 10, 85-103. (Pubitemid 38035558)
70. Liu, L., Dewar, L., Song, Y., Kulczycky, M., Blajchman, M. A., et al. (1995) Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thromb. Haemost. 73, 405-412.
71. Xian, X., Gopal, S., and, Couchman, J. R., (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. 339, 31-46.
72. Hammes, H.-P., Brownlee, M., Jonczyk, A., Sutter, A., and, Preissner, K. T., (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2, 529-533. (Pubitemid 26151516)
73. García de Yébenes, E., Ho, A., Damani, T., Fillit, H., and, Blum, M., (1999) Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1alpha. J. Neurochem. 73, 812-820. (Pubitemid 29339857)
74. Modrowski, D., Baslé, D., Lomri, A., and, Marie, P. J., (2000) Syndecan-2 Is Involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J. Biol. Chem. 275, 9178-9185. (Pubitemid 30185134)
75. Defilippi, P., Truffa, G., Stefanuto, G., Altruda, F., Silengo, L., et al. (1991) Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J. Biol. Chem. 266, 7638-7645. (Pubitemid 21906413)
76. Smith, J. W., Vestal, D. J., Irwin, S. V., Burke, T. A., and, Cheresh, D. A., (1990) Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin. J. Biol. Chem. 265, 11008-110013.
77. Zheng, F. F., Kuduk, S. D., Chiosis, G., Munster, P. N., Sepp-Lorenzino, L., et al. (2000) Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases. Cancer Res. 60, 2090-2094. (Pubitemid 30225164)
78. Dekker, R. J., Pannekoek, H., and, Horrevoets, A. J., (2003) A steady-state competition model describes the modulating effects of thrombomodulin on thrombin inhibition by plasminogen activator inhibitor-1 in the absence and presence of vitronectin. Eur. J. Biochem. 270, 1942-1951. (Pubitemid 36560815)
79. Moiseeva, E. P., Williams, B., and, Samani, N. J., (2003) Galectin 1 inhibits incorporation of vitronectin and chondroitin sulfate B into the extracellular matrix of human vascular smooth muscle cells. Biochim. Biophys. Acta 1619, 125-132. (Pubitemid 36078348)
80. Milis, L., Morris, C. A., Sheehan, M. C., Charlesworth, J. A., and, Pussell, B. A., (1993) Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clin. Exp. Immunol. 92, 114-119. (Pubitemid 23113908)
81. Seiffert, D., and, Schleef, R. R., (1996) Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. Blood 88, 552-560. (Pubitemid 26240387)
82. Schousboe, S. L., Egelund, R., Kirkegaard, T., Preissner, K. T., Rodenburg, K. W., et al. (2000) Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F. Thromb. Haemost. 83, 742-751. (Pubitemid 30248525)
83. Gechtman, Z., Belleli, A., Lechpammer, S., and, Shaltiel, S., (1997) The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies. Biochem. J. 325, 339-349.
84. Francois, P. P., Preissner, K. T., Herrmann, M., Haugland, R. P., Vaudaux, P., et al. (1999). Vitronectin interaction with glycosaminoglycans. Kinetics, structural determinants, and role in binding to endothelial cells. J. Biol. Chem. 274, 37611-37619. (Pubitemid 30026817)
85. Ehrlich, H. J., Gebbink, R. K., Keijer, J., Linders, M., Preissner, K. T., et al. (1990) Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. J. Biol. Chem. 265, 13029-13035.
86. Fay, W. P., Parker, A. C., Ansari, M. N., Zheng, X., and, Ginsburg, D., (1999) Vitronectin inhibits the thrombotic response to arterial injury in mice. Blood 93, 1825-1830. (Pubitemid 29128482)
87. Lijnen, H. R., and, Collen, D., (2008) Molecular and cellular basis of fibrinolysis. In Hematology: Basic Principles and Practice, Vol. 5. (, Hoffman, R., Benz, E. J. J., Shattil, S. J., and, Furie, B., eds.). Churchill Livingstone/Elsevier, Philadelphia, PA.
88. Pollack, G. H., (2001). Cells, gels and the engines of life. (A new, unifying approach to cell function). p. 305, Ebner and Sons, Seattle.
89. Ling, G. N., (2001) Life at the Cell and Below-Cell Level. The Hidden History of a Fundamental Revolution in Biology. pp. 74-108, Pacific Press, New York, ISBN 0-9707322-0-1.
90. Uchibori-Iwaki, H., Yoneda, A., Oda-Tamai, S., Kato, S., Akamatsu, N., et al. (2000) The changes in glycosylation after partial hepatectomy enhance collagen binding of vitronectin in plasma. Glycobiology 10, 865-874.
91. Sano, K., Asanuma-Date, K., Arisaka, F., Hattori, S., and, Ogawa, H., (2007) Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration. Glycobiology 17, 784-794. (Pubitemid 47050665)
92. Bobbink, I. W.G., de Boer, H. C., Tekelenburg, W. L. H., Banga, J.-D., and, de Groot, P. G., (1997) Effect of extracellular matrix glycation on endothelial cell adhesion and spreading. Diabetes 46, 87-93. (Pubitemid 27009955)
93. Malagolini, N., Catera, M., Osorio, H., Reis, C. A., Chiricolo, M., et al. (2013) Apoptotic cells selectively uptake minor glycoforms of vitronectin from serum. Apoptosis 18, 373-384.
94. Bae, H. B., Zmijewski, J. W., Deshane, J. S., Zhi, D., Thompson, L. C., et al. (2012) Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways. Am. J. Respir. Cell Mol. Biol. 46, 790-796.
95. Preissner, K. T., and, Reuning, U., (2011). Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin. Thromb. Hemost. 37, 408-424.
96. Felding-Habermann, B., and, Cheresh, D. A., (1993). Vitronectin and its receptors. Curr. Opin. Cell Biol. 5, 864-868.
97. Eliceiri, B. P., and, Cheresh, D. A., (1999). The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103, 1227-1230. (Pubitemid 29218291)
98. Harding, A. S., and, Hancock, J. F., (2008) Using plasma membrane nanoclusters to build better signaling circuits. Trends Cell Biol. 18, 364-371.
99. Zheng, X., Saunders, T. L., Camper, S. A., Samuelson, L. C., and, Ginsburg, D., (1995). Vitronectin is not essential for normal mammalian development and fertility. Proc. Natl. Acad. Sci. USA 92, 12426-12430. (Pubitemid 26014082)
100. Jang, Y. C., Tsou, R., Gibran, N. S., and, Isik, F. F., (2000). Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 127, 696-704. (Pubitemid 30399062)
101. Li, R., Ren, M., Chen, N., Luo, M., Zhang, Z., et al. (2012) Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. PLoS One 7, e37195.
102. Dvorak, H. F., (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl. J. Med. 315, 1650-1659. (Pubitemid 17052899)
103. Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., et al. (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49, 380-389; discussion, 390.
104. Bartsch, J. E., Staren, E. D., and, Appert, H. E., (2003). Adhesion and migration of extracellular matrix-stimulated breast cancer. J. Surg. Res. 110, 287-294. (Pubitemid 36403720)
105. Varner, J. A., and, Cheresh, D. A., (1996) Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv. Oncol. 69-87.
106. McDougall, S. R., Anderson, A. R. A., and, Chaplain, M. A. J., (2006). Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J. Theor. Biol. 241, 564-589. (Pubitemid 44041121)
107. Folkman, J., (2002) Role of angiogenesis in tumour growth and metastasis. Semin. Oncol. 29, 15-18.
108. Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C., and, Brown, R. A., (2002) Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349-363. (Pubitemid 34619269)
109. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., et al. (1994). Integrin avb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
110. Yi, M., Sakai, T., Fässler, R., and, Ruoslahti, E., (2003) Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc. Natl. Acad. Sci. 100, 11435-11438. (Pubitemid 37205953)
111. Gálvez, B. G., Matías-Román, S., Yáñez-Mõ, M., Sánchez-Madrid, F., Arroyo, A. G., (2002) ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J. Cell Biol. 159, 509-521. (Pubitemid 35332837)
112. Guiaur, G., Gerber, J., and, Jones, R. J., (2012) Concise review: cancer stem cells and minimal residual disease. Stem Cells 30, 89-93.
113. Karin, M., and, Greten, F. R., (2005) NF-kB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759. (Pubitemid 41400849)
114. Knox, P., (1984) Kinetics of cell spreading in the presence of different concentrations of serum or fibronectin-depleted serum. J. Cell Sci. 71, 51-59. (Pubitemid 15214576)
115. Steele, J. G., Johnson, G., Norris, W. D., and, Underwood, P. A., (1991) Adhesion and growth of cultured human endothelial cells on perfluorosulphonate: role of vitronectin and fibronectin in cell attachment. Biomaterials 12, 531-539.
116. Steele, J. G., Dalton, B. A., Johnson, G., and, Underwood, P. A., (1993) Polystyrene chemistry affects vitronectin activity: an explanation for cell attachment to tissue culture polystyrene but not to unmodified polystyrene. J. Biomed. Mater. Res. 27, 927-940. (Pubitemid 23178669)
117. Curtis, A. S., and, Forrester, J. V., (1984) The competitive effects of serum proteins on cell adhesion. J. Cell Sci. 71, 17-35. (Pubitemid 15214574)
118. Steele, J. G., Johnson, G., and, Underwood, P. A., (1992) Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene. J. Biomed. Mater. Res. 26, 861-884.
119. Bale, M. D., Wohlfahrt, L. A., Mosher, D. F., Tomasini, B., and, Sutton, R. C., (1989) Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition. Blood 74, 2698-2706. (Pubitemid 20007795)
120. Horbett, T. A., and, Lew, K. R., (1994) Residence time effects on monoclonal antibody binding to adsorbed fibrinogen. J. Biomater. Sci. Polym. Ed. 6, 15-33.
121. Underwood, P. A., and, Bennett, F. A., (1989) A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J. Cell Sci. 93, 641-649. (Pubitemid 19222382)
122. Noble, A., Towne, C., Chopin, L., Leavesley, D., and, Upton, Z., (2003) Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration. Endocrinology 144, 2417-2424. (Pubitemid 36629893)
123. Hyde, C., Hollier, B., Anderson, A., Harkin, D., and, Upton, Z., (2004) Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J. Invest. Dermatol. 122, 1198-1206. (Pubitemid 38651095)
124. Hollier, B. G., Kricker, J. A., Van Lonkhuyzen, D. R., Leavesley, D. I., and, Upton, Z., (2008) Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology 149, 1075-1090. (Pubitemid 351397938)
125. Kricker, J. A., Hyde, C., Van Lonkhuyzen, D. R., Hollier, B., Shooter, G. K., et al. (2010) Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin. Growth Factors 28, 359-369.
126. Kashyap, A. S., Hollier, B. G., Manton, K. J., Satyamoorthy, K., Leavesley, D. I., et al. (2011) Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration. Endocrinology 152, 1388-1401.
127. Zheng, J.-M., Chin, W. -C., Khijniak, E., Khijniak, E. Jr., Pollack, G. H., (2006) Surfaces and interfacial water: evidence that hydrophilic surfaces have long-range impact. Adv. Colloid Interface Sci. 127, 19-27. (Pubitemid 44854784)
128. Minton, A. P., (2001) The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J. Biol. Chem. 276, 10577-10580. (Pubitemid 38089223)
129. Simons, K., and, Gerl, M. J., (2010) Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell Biol. 11, 688-699.
130. Miyamoto, Y., Izumi, M., Ishizaka, S., and, Hayashi, M., (1989) Adsorption of vitronectin in human serum onto plastics is augmented by sodium dodecyl sulfate. Cell Struct. Funct. 14, 151-162. (Pubitemid 19147943)
131. Stupack, D. G., and, Cheresh, D. A., (2002) Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115, 3729-3738. (Pubitemid 35203599)
132. Abram, C. L., and, Lowell, C. A., (2009) The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 27, 339-362.
133. Harburger, D. S., and, Calderwood, D. A., (2009) Integrin signalling at a glance. J. Cell Sci. 122, 159-163.
134. Byzova, T. V., Kim, W., Midura, R. J., and, Plow, E. F., (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp. Cell Res. 254, 299-308. (Pubitemid 30080586)
135. Eliceiri, B.P., (2001) Integrin and growth factor receptor crosstalk. Circ. Res. 89, 1104-1110. (Pubitemid 34627867)
136. Schwartz, M. A., and, Ginsberg, M. H., (2002) Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4, E65-E68. (Pubitemid 34308840)